Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer

By Dalberg Kristina   Mattsson Anders   Sandelin Kerstin   Rutqvist Lars  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 69-78

Springer Publishing Company

Access to resources Recommend Favorite

Early distant relapse in early stage triple-negative breast cancer: usefulness of FDG-PET for diagnosis of distant metastases

By Hama Yukihiro  

Breast Cancer, Vol. 20, Iss. 2, 2013-04 ,pp. : 191-193

Springer Publishing Company

Access to resources Recommend Favorite

Population-based Estimate of the Prevalence of HER-2 Positive Breast Cancer Tumors for Early Stage Patients in the US

By Cronin Kathleen A.   Harlan Linda C.   Dodd Kevin W.   Abrams Jeffrey S.   Ballard-Barbash Rachel  

Cancer Investigation, Vol. 28, Iss. 9, 2010-10 ,pp. : 963-968

Informa Healthcare

Access to resources Recommend Favorite

Assessment of HER2 status in breast cancer - why, when and how?

By Dowsett M.   Cooke T.   Ellis I.   Gullick W.J.   Gusterson B.   Mallon E.   Walker R.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 170-176

Elsevier

Access to resources Recommend Favorite

Predicting distant dissemination in patients with early breast cancer

By Arriagada Rodrigo   Rutqvist Lars-erik   Johansson Hemming   Kramar Andrew   Rotstein Sam  

Acta Oncologica, Vol. 47, Iss. 6, 2008-08 ,pp. : 1113-1121

Informa Healthcare

Access to resources Recommend Favorite